SF3B1 and cancer: Over the past decade, SF3B1, SRSF2, U2AF1 and ZRSR2, splicing factors that are involved in early intron selection and pre-spliceosome assembly, have been identified as the most frequently mutated splicing factors in cancers based on the fast-developing next-generation sequencing techniques [9,10,13,16,26].